S-Methyl Cysteine Sulfoxide Does Not Ameliorate Weight Gain or Hyperlipidemia in Mice Fed a High-Fat Diet.

Autor: Hill CR; Nutrition and Health Innovation Research Institute, School of Medical and Health Science, Royal Perth Hospital Research Foundation, Edith Cowan University, Perth, Western Australia, 6000, Australia., Shafaei A; Centre for Integrative Metabolomics and Computational Biology, School of Science, Edith Cowan University, Joondalup, Australia, Western Australia, 6027., Matthews VB; Dobney Hypertension Centre, School of Biomedical Science, Royal Perth Hospital Unit, Royal Perth Hospital Medical Research Foundation, University of Western Australia, Perth, Western Australia, 6000, Australia., Ward NC; Dobney Hypertension Centre, Medical School, Royal Perth Hospital Unit, Royal Perth Hospital Medical Research Foundation, University of Western Australia, Perth, Western Australia, 6000, Australia., Croft KD; School of Biomedical Science, Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, 6000, Australia., Lewis JR; Nutrition and Health Innovation Research Institute, School of Medical and Health Science, Royal Perth Hospital Research Foundation, Edith Cowan University, Perth, Western Australia, 6000, Australia.; Medical School, University of Western Australia, Perth, Western Australia, 6000, Australia.; Centre for Kidney Research, Children's Hospital at Westmead School of Public Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, 2000, Australia., Hodgson JM; Nutrition and Health Innovation Research Institute, School of Medical and Health Science, Royal Perth Hospital Research Foundation, Edith Cowan University, Perth, Western Australia, 6000, Australia.; Medical School, University of Western Australia, Perth, Western Australia, 6000, Australia., Balmer L; Centre for Diabetes Research, Harry Perkins Institute for Medical Research, Nedlands, Western Australia, 6009, Australia.; Centre for Precision Health, School of Medical and Health Science, Edith Cowan University, Joondalup, Western Australia, Australia, 6027., Blekkenhorst LC; Nutrition and Health Innovation Research Institute, School of Medical and Health Science, Royal Perth Hospital Research Foundation, Edith Cowan University, Perth, Western Australia, 6000, Australia.; Medical School, University of Western Australia, Perth, Western Australia, 6000, Australia.

Publikováno v: Molecular nutrition & food research [Mol Nutr Food Res] 2024 May; Vol. 68 (10), pp. e2400034. Date of Electronic Publication: 2024 May 05.

SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes.

Autor: Herat LY; Dobney Hypertension Centre, School of Biomedical Sciences - Royal Perth Hospital Unit / Royal Perth Hospital Medical Research Foundation, University of Western Australia, Crawley, WA 6009, Australia., Matthews JR; Dobney Hypertension Centre, School of Biomedical Sciences - Royal Perth Hospital Unit / Royal Perth Hospital Medical Research Foundation, University of Western Australia, Crawley, WA 6009, Australia., Hibbs M; Research Centre, Royal Perth Hospital, Perth, WA 6000, Australia., Rakoczy EP; Department of Molecular Ophthalmology, University of Western Australia, Crawley, WA 6009, Australia., Schlaich MP; Dobney Hypertension Centre, Medical School - Royal Perth Hospital Unit / Royal Perth Hospital Medical Research Foundation, University of Western Australia, Crawley, WA 6009, Australia.; Department of Cardiology and Department of Nephrology, Royal Perth Hospital, Perth, WA 6000, Australia., Matthews VB; Dobney Hypertension Centre, School of Biomedical Sciences - Royal Perth Hospital Unit / Royal Perth Hospital Medical Research Foundation, University of Western Australia, Crawley, WA 6009, Australia.

Publikováno v: IScience [iScience] 2023 Jul 03; Vol. 26 (8), pp. 107260. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023).

Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy.

Autor: Herat LY; Dobney Hypertension Centre, School of Biomedical Sciences - Royal Perth Hospital Unit, University of Western Australia, Crawley, WA 6009, Australia., Matthews JR; Dobney Hypertension Centre, School of Biomedical Sciences - Royal Perth Hospital Unit, University of Western Australia, Crawley, WA 6009, Australia., Rakoczy EP; Department of Molecular Ophthalmology, University of Western Australia, Crawley, WA 6009, Australia., Schlaich MP; Dobney Hypertension Centre, Medical School - Royal Perth Hospital Unit, University of Western Australia, Crawley, WA 6009, Australia.; Department of Cardiology and Department of Nephrology, Royal Perth Hospital, Perth, WA 6000, Australia., Matthews VB; Dobney Hypertension Centre, School of Biomedical Sciences - Royal Perth Hospital Unit, University of Western Australia, Crawley, WA 6009, Australia.

Publikováno v: Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2023 Apr 27; Vol. 28 (4), pp. 83.

Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy.

Autor: Herat LY; Dobney Hypertension Centre, School of Biomedical Science - Royal Perth Hospital Unit, University of Western Australia, 6009 Crawley, WA, Australia., Matthews JR; Dobney Hypertension Centre, School of Biomedical Science - Royal Perth Hospital Unit, University of Western Australia, 6009 Crawley, WA, Australia., Ong WE; Dobney Hypertension Centre, School of Biomedical Science - Royal Perth Hospital Unit, University of Western Australia, 6009 Crawley, WA, Australia., Rakoczy EP; Department of Molecular Ophthalmology, University of Western Australia, 6009 Crawley, WA, Australia., Schlaich MP; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, University of Western Australia, 6009 Crawley, WA, Australia.; Department of Cardiology, Royal Perth Hospital, 6000 Perth, WA, Australia.; Department of Nephrology, Royal Perth Hospital, 6000 Perth, WA, Australia., Matthews VB; Dobney Hypertension Centre, School of Biomedical Science - Royal Perth Hospital Unit, University of Western Australia, 6009 Crawley, WA, Australia.

Publikováno v: Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2022 Dec 12; Vol. 27 (12), pp. 321.

Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches.

Autor: Carnagarin R; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Western Australia., Kiuchi MG; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Western Australia., Goh G; Department of Radiology, Alfred Hospital.; Department of Surgery, Central Clinical School, Monash University, Melbourne, Victoria., Adams L; Medical School, The University of Western Australia, Perth, Western Australia., Cohen N; Baker Heart and Diabetes Institute, Melbourne, Victoria., Kavnoudias H; Department of Radiology, Alfred Hospital., Gan SK; Department of Endocrinology, Medical School, The University of Western Australia., Van Schie G; Department of Radiology, Royal Perth Hospital, Perth, Western Australia., Esler MD; Human Neurotransmitter Lab., Matthews VB; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Western Australia., Schlaich MP; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth, Western Australia.; Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria.; Departments of Cardiology and Nephrology, Royal Perth Hospital, Perth, Western Australia, Australia.

Publikováno v: Journal of hypertension [J Hypertens] 2021 Aug 01; Vol. 39 (8), pp. 1478-1489.